BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1680 related articles for article (PubMed ID: 27256966)

  • 1. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
    Krueger K; Schmutz A; Zieger B; Kalbhenn J
    Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Anticoagulation Strategies in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation: Heparin Versus Bivalirudin.
    Rivosecchi RM; Arakelians AR; Ryan J; Murray H; Ramanan R; Gomez H; Phillips D; Sciortino C; Arlia P; Freeman D; Sappington PL; Sanchez PG
    Crit Care Med; 2021 Jul; 49(7):1129-1136. PubMed ID: 33711003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticoagulation Practices during Venovenous Extracorporeal Membrane Oxygenation for Respiratory Failure. A Systematic Review.
    Sklar MC; Sy E; Lequier L; Fan E; Kanji HD
    Ann Am Thorac Soc; 2016 Dec; 13(12):2242-2250. PubMed ID: 27690525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-Sparing Anticoagulation Strategies Are Viable Options for Patients on Veno-Venous ECMO.
    Carter KT; Kutcher ME; Shake JG; Panos AL; Cochran RP; Creswell LL; Copeland H
    J Surg Res; 2019 Nov; 243():399-409. PubMed ID: 31277018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a pharmacy managed heparin protocol for extracorporeal membrane oxygenation patients.
    Fitousis K; Klasek R; Mason PE; Masud F
    Perfusion; 2017 Apr; 32(3):238-244. PubMed ID: 27837164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding, Thrombosis, and Transfusion With Two Heparin Anticoagulation Protocols in Venoarterial ECMO Patients.
    Mazzeffi MA; Tanaka K; Roberts A; Rector R; Menaker J; Kon Z; Deatrick KB; Kaczorowski D; Griffith B; Herr D
    J Cardiothorac Vasc Anesth; 2019 May; 33(5):1216-1220. PubMed ID: 30181084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of anticoagulation strategy and agents on extracorporeal membrane oxygenation therapy.
    Macielak S; Burcham P; Whitson B; Abdel-Rasoul M; Rozycki A
    Perfusion; 2019 Nov; 34(8):671-678. PubMed ID: 31057056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes following routine antithrombin III replacement during neonatal extracorporeal membrane oxygenation.
    Stansfield BK; Wise L; Ham PB; Patel P; Parman M; Jin C; Mathur S; Harshfield G; Bhatia J
    J Pediatr Surg; 2017 Apr; 52(4):609-613. PubMed ID: 27847121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
    ; Sadeghipour P; Talasaz AH; Rashidi F; Sharif-Kashani B; Beigmohammadi MT; Farrokhpour M; Sezavar SH; Payandemehr P; Dabbagh A; Moghadam KG; Jamalkhani S; Khalili H; Yadollahzadeh M; Riahi T; Rezaeifar P; Tahamtan O; Matin S; Abedini A; Lookzadeh S; Rahmani H; Zoghi E; Mohammadi K; Sadeghipour P; Abri H; Tabrizi S; Mousavian SM; Shahmirzaei S; Bakhshandeh H; Amin A; Rafiee F; Baghizadeh E; Mohebbi B; Parhizgar SE; Aliannejad R; Eslami V; Kashefizadeh A; Kakavand H; Hosseini SH; Shafaghi S; Ghazi SF; Najafi A; Jimenez D; Gupta A; Madhavan MV; Sethi SS; Parikh SA; Monreal M; Hadavand N; Hajighasemi A; Maleki M; Sadeghian S; Piazza G; Kirtane AJ; Van Tassell BW; Dobesh PP; Stone GW; Lip GYH; Krumholz HM; Goldhaber SZ; Bikdeli B
    JAMA; 2021 Apr; 325(16):1620-1630. PubMed ID: 33734299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood and Anticoagulation Management in Extracorporeal Membrane Oxygenation for Surgical and Nonsurgical Patients: A Single-Center Retrospective Review.
    Buscher H; Vukomanovic A; Benzimra M; Okada K; Nair P
    J Cardiothorac Vasc Anesth; 2017 Jun; 31(3):869-875. PubMed ID: 28082026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation.
    Niebler RA; Parker H; Hoffman GM
    ASAIO J; 2019; 65(3):270-276. PubMed ID: 29746314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfractionated Heparin Versus Subcutaneous Nadroparin in Adults Supported With Venovenous Extracorporeal Membrane Oxygenation: a Retrospective, Multicenter Study.
    Piwowarczyk P; Borys M; Kutnik P; Szczukocka M; Sysiak-Sławecka J; Szułdrzyński K; Ligowski M; Drobiński D; Czarnik T; Czuczwar M
    ASAIO J; 2021 Jan; 67(1):104-111. PubMed ID: 32404610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous enoxaparin as alternative ECMO anticoagulation over a period of 94 days: a case report.
    Durila M; Berousek J; Vlasakova V; Vymazal T
    J Cardiothorac Surg; 2023 Apr; 18(1):137. PubMed ID: 37041623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study evaluating a non-titrating, weight-based anticoagulation scheme for patients on veno-venous extracorporeal membrane oxygenation.
    Deatrick KB; Galvagno SM; Mazzeffi MA; Kaczoroswki DJ; Herr DL; Rector R; Hochberg E; Rabinowitz RP; Scalea TM; Menaker J
    Perfusion; 2020 Jan; 35(1):13-18. PubMed ID: 31122144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Initial Anticoagulation Targets on Bleeding and Thrombotic Complications for Patients With Acute Respiratory Distress Syndrome Receiving Extracorporeal Membrane Oxygenation.
    Cercone JL; Kram SJ; Trammel MA; Rackley CR; Lee HJ; Merchant J; Kram BL
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3561-3569. PubMed ID: 35691853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-xa directed protocol for anticoagulation management in children supported with extracorporeal membrane oxygenation.
    O'Meara LC; Alten JA; Goldberg KG; Timpa JG; Phillips J; Laney D; Borasino S
    ASAIO J; 2015; 61(3):339-44. PubMed ID: 25710768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal membrane oxygenation-hemostatic complications.
    Murphy DA; Hockings LE; Andrews RK; Aubron C; Gardiner EE; Pellegrino VA; Davis AK
    Transfus Med Rev; 2015 Apr; 29(2):90-101. PubMed ID: 25595476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation.
    Guo Z; Sun L; Li B; Tian R; Zhang X; Zhang Z; Clifford SP; Liu Y; Huang J; Li X
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):389-397. PubMed ID: 32994131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Argatroban for Heparin-Induced Thrombocytopenia during Venovenous Extracorporeal Membrane Oxygenation with Continuous Venovenous Hemofiltration.
    Sin JH; Lopez ND
    J Extra Corpor Technol; 2017 Jun; 49(2):115-120. PubMed ID: 28638161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation.
    Berei TJ; Lillyblad MP; Wilson KJ; Garberich RF; Hryniewicz KM
    ASAIO J; 2018; 64(5):623-629. PubMed ID: 29076942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 84.